Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA)
CUSIP: 92511W108
Q3 2022 13F Holders as of 30 Sep 2022
- Type / Class
- Equity / Common Stock, $0.0001 par value
- Shares outstanding
- 92,448,158
- Total 13F shares
- 10,245,689
- Share change
- -1,074,242
- Total reported value
- $29,916,489
- Put/Call ratio
- 175%
- Price per share
- $2.92
- Number of holders
- 46
- Value change
- -$2,471,402
- Number of buys
- 20
- Number of sells
- 24
Quarterly Holders Quick Answers
What is CUSIP 92511W108?
CUSIP 92511W108 identifies VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 92511W108:
Top shareholders of VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
5.5%
|
5,038,983
|
$9,675,000 | — | 30 Jun 2022 | |
| FMR LLC |
13F
|
Company |
1.7%
|
1,597,975
|
$3,068,000 | — | 30 Jun 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.1%
|
1,012,596
|
$1,945,000 | — | 30 Jun 2022 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.82%
|
753,945
|
$1,448,000 | — | 30 Jun 2022 | |
| CVI Holdings, LLC |
13F
|
Company |
0.49%
|
450,000
|
$864,000 | — | 30 Jun 2022 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.33%
|
302,841
|
$581,000 | — | 30 Jun 2022 | |
| Fosun International Ltd |
13F
|
Company |
0.31%
|
282,408
|
$543,000 | — | 30 Jun 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.23%
|
211,559
|
$407,000 | — | 30 Jun 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.2%
|
181,929
|
$349,000 | — | 30 Jun 2022 | |
| SteelPeak Wealth, LLC |
13F
|
Company |
0.15%
|
134,661
|
$259,000 | — | 30 Jun 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.14%
|
133,734
|
$257,000 | — | 30 Jun 2022 | |
| KORNITZER CAPITAL MANAGEMENT INC /KS |
13F
|
Company |
0.14%
|
129,251
|
$248,000 | — | 30 Jun 2022 | |
| Composition Wealth, LLC |
13F
|
Company |
0.14%
|
125,000
|
$240,000 | — | 30 Jun 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.13%
|
121,144
|
$232,000 | — | 30 Jun 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.1%
|
93,961
|
$181,000 | — | 30 Jun 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.09%
|
82,816
|
$159,000 | — | 30 Jun 2022 | |
| Ergoteles LLC |
13F
|
Company |
0.07%
|
64,300
|
$123,000 | — | 30 Jun 2022 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.06%
|
54,267
|
$104,000 | — | 30 Jun 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.05%
|
47,900
|
$92,000 | — | 30 Jun 2022 | |
| MML INVESTORS SERVICES, LLC |
13F
|
Company |
0.05%
|
43,900
|
$84,000 | — | 30 Jun 2022 | |
| A. Brian Davis |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
12,900
|
$83,721 | — | 04 Jun 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.04%
|
41,505
|
$80,000 | — | 30 Jun 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.04%
|
41,449
|
$80,000 | — | 30 Jun 2022 | |
| OCCUDO QUANTITATIVE STRATEGIES LP |
13F
|
Company |
0.04%
|
38,687
|
$74,000 | — | 30 Jun 2022 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.04%
|
32,600
|
$62,000 | — | 30 Jun 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.03%
|
31,750
|
$61,000 | — | 30 Jun 2022 | |
| BECK MACK & OLIVER LLC |
13F
|
Company |
0.03%
|
30,000
|
$58,000 | — | 30 Jun 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.03%
|
26,193
|
$50,000 | — | 30 Jun 2022 | |
| XTX Topco Ltd |
13F
|
Company |
0.03%
|
25,795
|
$50,000 | — | 30 Jun 2022 | |
| Virtu Financial LLC |
13F
|
Company |
0.03%
|
24,690
|
$47,000 | — | 30 Jun 2022 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.03%
|
24,550
|
$47,000 | — | 30 Jun 2022 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.02%
|
18,808
|
$36,000 | — | 30 Jun 2022 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
16,667
|
$32,000 | — | 30 Jun 2022 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.02%
|
14,606
|
$28,000 | — | 30 Jun 2022 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.01%
|
12,678
|
$24,342 | — | 30 Jun 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.01%
|
11,563
|
$22,000 | — | 30 Jun 2022 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.01%
|
11,353
|
$22,000 | — | 30 Jun 2022 | |
| TRUIST FINANCIAL CORP |
13F
|
Company |
0.01%
|
11,298
|
$21,000 | — | 30 Jun 2022 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.01%
|
10,579
|
$20,000 | — | 30 Jun 2022 | |
| Ground Swell Capital, LLC |
13F
|
Company |
0.01%
|
10,205
|
$20,000 | — | 30 Jun 2022 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.01%
|
10,146
|
$19,000 | — | 30 Jun 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
6,442
|
$12,000 | — | 30 Jun 2022 | |
| Spire Wealth Management |
13F
|
Company |
0%
|
3,827
|
$7,000 | — | 30 Jun 2022 | |
| UBS Group AG |
13F
|
Company |
0%
|
3,413
|
$7,000 | — | 30 Jun 2022 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
1,237
|
$2,000 | — | 30 Jun 2022 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0%
|
1,200
|
$2,000 | — | 30 Jun 2022 | |
| Asset Dedication, LLC |
13F
|
Company |
0%
|
1,193
|
$2,000 | — | 30 Jun 2022 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
1,102
|
$2,000 | — | 30 Jun 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
1,077
|
$2,000 | — | 30 Jun 2022 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0%
|
931
|
$2,000 | — | 30 Jun 2022 |
Institutional Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) as of Q3 2022
As of 30 Sep 2022,
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) was held by
46 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,245,689 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, FMR LLC, VANGUARD GROUP INC, Point72 Asset Management, L.P., Fosun International Ltd, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, Steel Peak Wealth Management LLC, and KORNITZER CAPITAL MANAGEMENT INC /KS.
This page lists
46
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
51
Q3 2022 holders
46
Holder diff
-5
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 Value $ | Q3 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.